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Abstract 
Background: The majority of genetic biomarkers for human cancers are defined by statistical 
screening of high-throughput genomics data. While a large number of genetic biomarkers have been 
proposed for diagnostic and prognostic applications, only a small number have been applied in the 
clinic. Similarly, the use of proteomics methods for the discovery of cancer biomarkers is 
increasing. The emerging field of proteogenomics seeks to enrich the value of genomics and 
proteomics approaches by studying the intersection of genomics and proteomics data. This task is 
challenging due to the complex nature of transcriptional and translation regulatory mechanisms and 
the disparities between genomic and proteomic data from the same samples. In this study, we have 
examined tumor antigens as potential biomarkers for breast cancer using genomics and proteomics 
data from previously reported laser capture microdissected ER+ tumor samples. Results: We applied 
proteogenomic analyses to study the genetic aberrations of 32 tumor antigens determined in the 
proteomic data. We found that tumor antigens that are aberrantly expressed at the genetic level and 
expressed at the protein level, are likely involved in perturbing pathways directly linked to the 
hallmarks of cancer. The results found by proteogenomic analysis of the 32 tumor antigens studied 
here, capture largely the same pathway irregularities as those elucidated from large-scale screening 
of genomics analyses, where several thousands of genes are often found to be perturbed. 
Conclusion: Tumor antigens are a group of proteins recognized by the cells of the immune system. 
Specifically, they are recognized in tumor cells where they are present in larger than usual amounts, 
or are physiochemically altered to a degree at which they no longer resemble native human proteins. 
This proteogenomic analysis of 32 tumor antigens suggests that tumor antigens have the potential to 
be highly specific biomarkers for different cancers. 
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